Michael H Weinstein

Summary

Affiliation: WakeMed Health and Hospitals
Country: USA

Publications

  1. ncbi request reprint Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells
    Michael H Weinstein
    Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Mod Pathol 15:1302-8. 2002
  2. ncbi request reprint The role of the pathologist in diagnosing prostate cancer and guiding therapy
    Michael H Weinstein
    Pathology Laboratories, WakeMed Health and Hospitals in Raleigh, NC, USA
    N C Med J 67:140-5. 2006
  3. ncbi request reprint Prostate carcinoma tissue proteomics for biomarker discovery
    Yaxin Zheng
    Molecular Urology Laboratory, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 98:2576-82. 2003
  4. doi request reprint The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy
    Paul L Nguyen
    Harvard Radiation Oncology Program, Brigham and Women s Hospital Dana Farber Cancer Institute, Boston, MA 02115, USA
    Urol Oncol 29:302-8. 2011
  5. ncbi request reprint Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?
    Patrick W Linson
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts 02215, USA
    Urology 59:704-8. 2002
  6. ncbi request reprint An objective measure of architectural complexity and proliferative index in Gleason pattern 3 prostate cancer
    Michael H Weinstein
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Anal Quant Cytol Histol 24:280-8. 2002

Collaborators

Detail Information

Publications6

  1. ncbi request reprint Diagnostic utility of immunohistochemical staining for p63, a sensitive marker of prostatic basal cells
    Michael H Weinstein
    Department of Pathology, Brigham and Women s Hospital, Boston, Massachusetts, USA
    Mod Pathol 15:1302-8. 2002
    ..No false-positive staining was seen. We conclude that p63 staining is at least as sensitive and specific for the identification of basal cells in diagnostic prostate specimens as is high molecular weight cytokeratin staining...
  2. ncbi request reprint The role of the pathologist in diagnosing prostate cancer and guiding therapy
    Michael H Weinstein
    Pathology Laboratories, WakeMed Health and Hospitals in Raleigh, NC, USA
    N C Med J 67:140-5. 2006
    ..Such work continues to be integral to scientific advancement in these areas...
  3. ncbi request reprint Prostate carcinoma tissue proteomics for biomarker discovery
    Yaxin Zheng
    Molecular Urology Laboratory, Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA
    Cancer 98:2576-82. 2003
    ..Proteins were involved in various pathways that determine the behavior of a cell. Therefore, information regarding proteins may reveal drug targets and/or markers for early detection...
  4. doi request reprint The impact of Skp2 overexpression on recurrence-free survival following radical prostatectomy
    Paul L Nguyen
    Harvard Radiation Oncology Program, Brigham and Women s Hospital Dana Farber Cancer Institute, Boston, MA 02115, USA
    Urol Oncol 29:302-8. 2011
    ..We examined whether Skp2 overexpression is associated with recurrence following radical prostatectomy (RP) for prostate cancer...
  5. ncbi request reprint Percentage of core lengths involved with prostate cancer: does it add to the percentage of positive prostate biopsies in predicting postoperative prostate-specific antigen outcome for men with intermediate-risk prostate cancer?
    Patrick W Linson
    Joint Center for Radiation Therapy, Harvard Medical School, Boston, Massachusetts 02215, USA
    Urology 59:704-8. 2002
    ....
  6. ncbi request reprint An objective measure of architectural complexity and proliferative index in Gleason pattern 3 prostate cancer
    Michael H Weinstein
    Department of Pathology, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Anal Quant Cytol Histol 24:280-8. 2002
    ..To objectively characterize the architectural spectrum of Gleason pattern 3 prostate cancer (PCA) in a biologically meaningful manner...